Cargando…
Intravenous Administration of Adenoviruses Targeting Transforming Growth Factor Beta Signaling Inhibits Established Bone Metastases in 4T1 Mouse Mammary Tumor Model in an Immunocompetent Syngeneic Host
We have examined the effect of adenoviruses expressing soluble transforming growth factor receptorII-Fc (sTGFβRIIFc) in a 4T1 mouse mammary tumor bone metastasis model using syngeneic BALB/c mice. Infection of 4T1 cells with a non-replicating adenovirus, Ad(E1-).sTβRFc, or with two oncolytic adenovi...
Autores principales: | Zhang, Zhenwei, Hu, Zebin, Gupta, Janhavi, Krimmel, Jeffrey, Gerseny, Helen, Berg, Arthur, Robbins, John, Du, Hongyan, Prabhakar, Bellur, Seth, Prem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3424293/ https://www.ncbi.nlm.nih.gov/pubmed/22744210 http://dx.doi.org/10.1038/cgt.2012.41 |
Ejemplares similares
-
The Safety and Efficacy of Systemic Delivery of a New Liver-de-targeted TGFβ Signaling Inhibiting Adenovirus in an Immunocompetent Triple Negative Mouse Mammary Tumor Model
por: Xu, Weidong, et al.
Publicado: (2023) -
Oncolytic adenovirus targeting cyclin E overexpression repressed tumor growth in syngeneic immunocompetent mice
por: Cheng, Pei-Hsin, et al.
Publicado: (2015) -
Establishment of a syngeneic orthotopic model of prostate cancer in immunocompetent rats
por: Suzuki, Shugo, et al.
Publicado: (2014) -
A modified hTERT Promoter-directed Oncolytic Adenovirus Replication with Concurrent Inhibition of TGFβ Signaling for Breast Cancer Therapy
por: Hu, Zebin, et al.
Publicado: (2009) -
Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model
por: Garofalo, Mariangela, et al.
Publicado: (2021)